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Abstract
Background: Paediatric research analysing the relationship between the easy-to-use anthropometric measures for
adiposity and cardiometabolic risk factors remains highly controversial in youth. Several studies suggest that only
body mass index (BMI), a measure of relative weight, constitutes an accurate predictor, whereas others highlight
the potential role of waist-to-hip ratio (WHR), waist circumference (Waist C), and waist-to-height ratio (WHtR). In this
study, we examined the effectiveness of adding anthropometric measures of body fat distribution (Waist C Z Score,
WHR Z Score and/or WHtR) to BMI Z Score to predict cardiometabolic risk factors in overweight and obese youth.
We also examined the consistency of these associations with the “total fat mass + trunk/legs fat mass” and/or the
“total fat mass + trunk fat mass” combinations, as assessed by dual energy X-ray absorptiometry (DXA), the gold
standard measurement of body composition.
Methods: Anthropometric and DXA measurements of total and regional adiposity, as well as a comprehensive
assessment of cardiometabolic, inflammatory and adipokines profiles were performed in 203 overweight and obese
7–17 year-old youths from the Paediatrics Clinic, Centre Hospitalier de Luxembourg.
Results: Adding only one anthropometric surrogate of regional fat to BMI Z Score improved the prediction of
insulin resistance (WHR Z Score, R2: 45.9 %. Waist C Z Score, R2: 45.5 %), HDL-cholesterol (WHR Z Score, R2: 9.6 %.
Waist C Z Score, R2: 10.8 %. WHtR, R2: 6.5 %), triglycerides (WHR Z Score, R2: 11.7 %. Waist C Z Score, R2: 12.2 %),
adiponectin (WHR Z Score, R2: 14.3 %. Waist C Z Score, R2: 17.7 %), CRP (WHR Z Score, R2: 18.2 %. WHtR, R2: 23.3 %),
systolic (WHtR, R2: 22.4 %), diastolic blood pressure (WHtR, R2: 20 %) and fibrinogen (WHtR, R2: 21.8 %). Moreover,
WHR Z Score, Waist C Z Score and/or WHtR showed an independent significant contribution according to these
models. These results were in line with the DXA findings.
Conclusions: Adding anthropometric measures of regional adiposity to BMI Z Score improves the prediction of
cardiometabolic, inflammatory and adipokines profiles in youth.
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Background
Several studies have focused on the presence of early
biological abnormalities in excess-weight youths, including
elevated fasting glycaemia, insulin resistance, hypertri-
glyceridemia, high-density lipoprotein cholesterol (HDL-
cholesterol), elevated blood pressure and causing several
comorbidities in adults [1–5]. Furthermore, some adipo-
kines, namely leptin, adiponectin and resistin, have been
identified as potential risk markers for a systemic low-grade
inflammation state, which might lead to insulin resistance,
type-2 diabetes and cardiovascular (CV) diseases [6–8].
Moreover, beyond global excess weight, the role of the
abdominovisceral adiposity as independent cardiometa-
bolic risk factor has been underlined from children on-
wards [9], while more peripheral fat has been considered
as protective [10].
Magnetic Resonance Imaging (MRI), Computed
Tomography-Scan (CT-Scan) and Dual-energy X ray Ab-
sorptiometry (DXA) have been described as the gold stand-
ard of adiposity measurement and used to accurately assess
body fat distribution and related comorbidities [9, 11, 12].
However, these techniques are still no accessible because of
their high cost and irradiation in the case of CT-Scan mea-
surements as well [11, 12].
Therefore, in order to assess the comorbidities associated
with overweight and obesity and abdomino-visceral adi-
posity in youths, the identification of simple and accurate
anthropometric methods that can be used with efficiency
as clinical and research tools is essential.
Studies analysing the relationship between the easy-to-
use anthropometric measures for total fat mass, body fat
distribution and cardiometabolic risk factors are highly
controversial when it comes to youths. Several authors
suggested that only body mass index (BMI) constitutes
an accurate predictor of biological abnormalities and
cardiometabolic impairments [13–17], whereas others
highlighted the role of the waist-to-hip ratio (WHR)
[18, 19], waist circumference (Waist C) [20, 21] and/or
waist-to-height ratio (WHtR) [22, 23]. Furthermore,
certain studies showed no significant differences in the
ability of BMI and WHR [24], BMI and Waist C [25],
BMI and WHtR [26], as well as Waist C and WHtR [27] to
predict cardiometabolic risk factors. Finally, in some other
studies, differential associations were observed between CV
risk factors and anthropometric measures [28, 29].
In adults, extensive studies showed that adding an-
thropometric measures of body fat distribution such as
WHR or Waist C, to BMI, allows predicting CV risk fac-
tors, diseases and death more accurately [2, 30–34]. This
type of associations has not really been developed in
paediatric populations. Indeed, in an attempt to predict
cardiometabolic risk factors in youths, some previous
paediatric studies either tested the efficiency of a single
anthropometric measurement [14, 21, 23, 25] or assessed
the contribution of BMI only as a potential confounder
of other variables involved [18, 20, 27, 29].
The present study investigated the ability of the “BMI
and Waist C”, “BMI and WHR” and/or “BMI and WHtR”
associations to predict cardiometabolic risk factors in over-
weight and obese youths. The consistency of our findings
was evaluated by assessing the ability to predict the same
risk factors presented by the associations between total fat
mass and trunk fat mass, respectively total fat mass and
trunk/legs fat mass as obtained by dual energy X-ray
absorptiometry (DXA), which is the body-composition
gold-standard analysis.
Methods
Participants
Two hundred three overweight and/or obese children
(52.2 % female) according to the IOTF definition [35],
aged 7 to17 years old, and visiting the Diabetes &
Endocrinology Care Paediatrics Clinic, Centre Hospitalier
de Luxembourg, were invited to participate in a cross-
sectional study performed between September 2006
and June 2008. The parents gave their written informed
consent. The study was approved by the National Ethics
Committee and authorized by the National Commission
for Data Protection in Luxembourg.
Anthropometry and body composition
Height, weight, waist and hip circumferences have been
performed according to the recommendations of Lohmann
[36]. BMI, WHR and WHtR ratios were calculated. Total,
trunk and legs fat masses were measured by DXA using
the Hologic®QDR4500W densitometer. Trunk/legs fat mass
index was calculated.
Clinical and biological measurements
Blood pressures was measured with an aneroid sphyg-
momanometer (Welch AL) in the sitting position: 3
readings were performed and the average was retained.
Systolic blood pressure (SBP) and diastolic blood pressure
(DBP) Z Scores were calculated according to the formula
proposed by The Fourth Report on the Diagnosis, Evalu-
ation, and Treatment of High Blood Pressure in Children
and Adolescents [37]. Roche reagents on a P module of
Roche Modular (Basel, Switzerland) were used to assess
fasting glucose, triglycerides, HDL-cholesterol and low-
density lipoprotein cholesterol (LDL-cholesterol). An
Olympus latex reagent was used on the same P module
of a Roche Modular to measure C-reactive protein (CRP).
A chimiluminescent assay on Siemens Immulite 2000
(Deerfield, USA) was used to measure fasting insulin.
Fibrinogen was assessed on Stago Compact (Asnières
sur Seine, France). ELISA kits provided by Mediagnost
(Reutlingen, Germany) were used to assess leptin, adipo-
nectin and resistin. We also calculated the homeostasis
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model assessment of insulin resistance [HOMA IR = fasting
insulin (μU/ml) × fasting glucose (mmol/l)/22.5] [38] and
the quantitative insulin sensitivity check index [QUICKI
index = 1/(log fasting insulin in μU/ml + log glucose in
mg/dl)] [39]. Tanner stages were assessed [40, 41].
Statistical analyses
The combination of the Kolmogorov-Smirnov test and
of the Lilliefors’ test was used to check the normal data
distribution. Triglycerides, HDL cholesterol, fasting insu-
lin, HOMA IR, CRP, fibrinogen, adiponectin, leptin and
resistin were log transformed (skewed variables).
Mean ± sd and/or percentages were calculated and
compared by the Student’s t test (descriptive data). In
the absence of national L,M,S data, BMI, Waist C and
WHR Z Scores, as well as the overweight (boys: ≥ 91th
percentile; girls: ≥ 89th percentile) and obesity (≥99th
percentile) thresholds, were defined according to the L,
M, S Dutch values [42, 43] and the IOTF definition [35].
Anthropometric and DXA prediction of cardiometabolic risk
factors
To test the ability of each single anthropometric variable
to predict the risk factors, the univariate linear analysis
[Pearson’s R] was used. To assess the combined effect of
the “BMI and Waist C”, “BMI and WHR”, “BMI and
WHtR” as well as “total and trunk fat masses” and “total
and trunk/legs fat masses” associations on the prediction
of the risk factors, multivariable linear analyses were per-
formed. An additional effect of Waist C Z Score, WHR
Z Score and/or WHtR was highlighted when 1.the global
variance of the model (R2) was improved and 2.the vari-
able showed an independent significant contribution to
the model (significant r2partial), independently of the BMI
Z Score. All models were age-, sex- and pubertal status
adjusted. To test the consistency of the anthropometry
and DXA findings, similar analyses were performed to
assess the potential additional impact of the trunk fat
mass and/or the trunk/legs fat index, beyond the total fat
mass. Results with a p-value < 0.05 were considered statis-
tically significant. Statistical analyses were performed using
SPSS® for Windows Version 17.0.
Results
The anthropometric, body composition and biological
characteristics of the participants are summarized in
Table 1.
Relationships between single anthropometric variables
and CV risk factors
BMI Z Score was the most accurate single predictor of
fasting glucose, fasting insulin, HOMA IR, QUICKI,
leptin and resistin. Triglycerides and HDL cholesterol
were most accurately predicted by Waist C Z Score.
Blood pressure, CRP and fibrinogen were most accur-
ately predicted by WHtR. WHR Z Score was the most
accurate single predictor of adiponectin (Table 2).
Table 1 Subject characteristics
Girls Boys All children
N 106 97 203
Age (years) 12.2 ± 2.5 11.8 ± 2.4 12.0 ± 2.4
Pubertal status (Percentages)
Yes 84 (79.2 %) 47 (48.5 %) 131 (64.5 %)
No 22 (20.8 %) 50 (51.5 %) 72 (35.5 %)
Anthropometry
BMI (kg/m2) 28.5 ± 5.6 28.2 ± 4.9 28.3 ± 5.3
BMI Z score 2.42 ± 0.58 2.68 ± 0.53* 2.54 ± 0.57
Waist C (cm) 83.8 ± 12.4 86.5 ± 11.5 85.1 ± 12.0
Waist C Z score 2.22 ± 0.63 2.46 ± 0.58* 2.33 ± 0.62
WHtRa 0.54 ± 0.06 0.56 ± 0.05* 0.55 ± 0.06
WHRb 0.84 ± 0.06 0.89 ± 0.05** 0.86 ± 0.06
WHR Z score 0.71 ± 0.89 0.85 ± 0.95 0.78 ± 0.92
Biology
Fasting glucose (mg/dl) 86.2 ± 6.8 86.9 ± 6.2 86.5 ± 6.5
Fasting insulin (mUI/l) 17.5 ± 8.5 14.8 ± 8.3* 16.2 ± 8.5
HOMA IR 3.76 ± 1.98 3.21 ± 1.87* 3.50 ± 1.94
QUICKI 0.321 ± 0.024 0.330 ± 0.027* 0.326 ± 0.026
Triglycerides (mg/dl) 98.4 ± 58.4 90.0 ± 51.1 94.3 ± 55.1
HDL cholesterol (mg/dl) 54.4 ± 12.7 52.9 ± 12.1 53.7 ± 12.4
LDL cholesterol (mg/dl) 92.3 ± 29.0 93.0 ± 28.2 92.6 ± 28.6
CRP (mg/l) 2.9 ± 4.1 3.2 ± 3.8 3.1 ± 4.0
Fibrinogen (g/l) 3.7 ± 0.7 3.6 ± 0.6 3.6 ± 0.7
Adiponectin (μg/ml) 8.0 ± 4.7 7.8 ± 4.5 7.9 ± 4.6
Leptin (ng/ml) 38.7 ± 23.1 27.4 ± 16.1** 33.3 ± 20.8
Resistin (ng/ml) 5.3 ± 2.2 5.1 ± 2.0 5.2 ± 2.1
DXA
Total fat mass (kg) 32.51 ± 14.29 30.11 ± 10.85 31.37 ± 12.80
Trunk fat mass (kg) 15.07 ± 7.14 14.17 ± 5.87 14.64 ± 6.57
Trunk/legs fat mass index 1.22 ± 0.24 1.27 ± 0.28 1.24 ± 0.26
Blood pressure
SBP (mmHg) 117 ± 12 118 ± 14 117 ± 13
SBP Z score 0.99 ± 1.04 0.91 ± 1.10 0.95 ± 1.07
DBP (mmHg) 71 ± 9 72 ± 8 72 ± 9
DBP Z score 0.75 ± 0.78 0.81 ± 0.64 0.78 ± 0.71
Data are N and/or means ± SD
*P-value < 0.05; ** P-value < 0.001 for sex difference
aWHtR (waist to height ratio)
bWHR (waist-to-hip ratio)
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Prediction of CV risk factors using models adding
anthropometric surrogates of body fat distribution to
general adiposity measurements
The initial model including BMI Z Score, age, sex and
pubertal status accounted for respectively 7.4, 43.7, 42.7,
41.4, 7.9, 4.3, 18.8, 17.5, 14.6, 19.9, 10, 50.2 and 9.5 % of the
fasting glucose, insulin, HOMA IR, QUICKI, triglycerides,
HDL-cholesterol, SBP Z Score, DBP Z Score, CRP, fibrino-
gen, adiponectin, leptin and resistin variances.
Adding WHR Z Score improved fasting insulin (R2:
45.9 %; r2partial: 3.9 %), HOMA IR (R
2: 44.7 %; r2partial: 3.6 %),
QUICKI (R2: 43.3 %; r2partial: 3.3 %), HDL-cholesterol (R
2:
9.6 %; r2partial: 5.6 %), triglycerides (R
2: 11.7 %; r2partial: 4.2 %),
adiponectin (R2: 14.3 %; r2partial: 4.7 %) and CRP (R
2: 18.2 %.;
r2partial: 4.3 %) prediction.
Associating Waist C Z Score with BMI Z Score, age,
sex and pubertal status showed similar findings except
for CRP. Indeed, Waist C Z Score accounted for 3.2 %
of fasting insulin variance (R2: 45.5 %), respectively for
2.6 % of HOMA IR (R2: 44.2 %), 2.5 % of QUICKI (R2:
42.9 %), 6.8 % of HDL-cholesterol (R2: 10.8 %), 4.7 % of
triglycerides (R2: 12.2 %) and 8.5 % of adiponectin (R2:
17.7 %) variances.
Associated with BMI Z Score, age, sex and pubertal
status, WHtR accounted for 2.4 % of the HDL-cholesterol
variance (R2: 6.5 %), respectively for 4.4 % of the SBP Z
Score (R2: 22.4 %), 3 % of the DBP Z Score (R2: 20 %),
10.2 % of the CRP (R2: 23.3 %) and 2.4 % of the fibrinogen
(R2: 21.8 %) variances (Table 3).
Finally, as regards DXA measurements, apart from fasting
glucose, LDL cholesterol, fibrinogen and leptin, the DXA
prediction of every other cardiometabolic risk factor was
improved when the trunk/legs fat mass index was added to
total fat mass, as well as after the addition of trunk fat mass
to total fat mass (models were adjusted on age, sex and
pubertal status) (Table 4).
Discussion
Our study clearly showed that, in addition to global
overweight and obesity, body fat distribution, as assessed
by anthropometry, significantly and independently con-
tributes to the prediction of CV risk factors in overweight
and obese youth. Insulin resistance markers, in particular,
were more accurately predicted by adding WHR Z Score
or Waist C Z Score to BMI Z Score. HDL cholesterol was
unanimously more accurately predicted by adding to BMI
Z Score one of the three selected anthropometric surro-
gates for body fat distribution. Triglyceride concentration
was more accurately predicted after adding either WHR Z
Score or Waist C Z Score to BMI Z Score. Inflammation,
as assessed by C-reactive protein, had its prediction im-
proved when WHR Z Score and/or WHtR were added to
BMI Z Score. WHtR played a similar role in the case of fi-
brinogen. WHtR played a role also in blood pressure pre-
diction, after combination with BMI Z Score. Adiponectin
concentrations seem to be better approached by combin-
ing WHR or Waist C Z Scores with BMI Z Score, while
resistin and leptin predictions were not affected by the an-
thropometric measures for body fat distribution. This was
also the case of glucose concentrations, the prediction of
which was not affected beyond BMI neither by WHR and
Waist C Z Scores nor by WHtR. On the other hand, our
Table 2 Relationships between a single anthropometric measurement and biological variables
Variable BMI Z score Waist C Z score WHtR WHR Z score
Pearson’s R
Fasting glucose 0.235* 0.176* 0.193* 0.057
Fasting insulina 0.490** 0.483** 0.463** 0.295**
HOMA IRa 0.493** 0.480** 0.463** 0.290**
QUICKI −0.475** −0.463** −0.444** −0.283**
Triglyceridesa 0.205* 0.270** 0.250** 0.249**
HDL cholesterola −0.205* −0.293** −0.252** −0.273**
LDL cholesterol −0.047 −0.013 0.003 0.018
SBP Z score 0.385** 0.389** 0.433** 0.198*
DBP Z score 0.392** 0.353** 0.418** 0.186*
CRPa 0.374** 0.388** 0.472** 0.261**
Fibrinogena 0.341** 0.316** 0.375** 0.193*
Adiponectina −0.187* −0.277** −0.201* −0.279**
Leptina 0.551** 0.498** 0.546** 0.119
Resistina 0.229* 0.181* 0.191* 0.064
Data are Pearson’s R (univariate linear analysis) for single biological variables
*P-value < 0.05; **P-value < 0.001
aLog-transformed variables
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Table 3 Multivariable anthropometric prediction of cardiovascular risk factors in youths
Dependent variable Model 1: BMI Z Score Model 2: BMI Z Score, WHR Z Score Model 3: BMI Z Score, Waist C Z Score Model 4: BMI Z Score, WHtR
R2 model 1 R2 model 2 r2 partial BMI Z Score r
2 partial WHR Z Score R
2 model 3 r2 partial BMI Z Score r
2 partial waist C Z Score R
2 model 4 r2 partial BMI Z Score r
2 partial
WHtR
Fasting glucose 0.074* 0.074* 0.042* 0.000 0.080* 0.027* 0.007 0.074* 0.014 0.000
Fasting insulina 0.437** 0.459** 0.266** 0.039* 0.455** 0.016 0.032* 0.440** 0.071** 0.005
HOMA IRa 0.427** 0.447** 0.262** 0.036* 0.442** 0.019 0.026* 0.430** 0.070** 0.005
QUICKI 0.414** 0.433** 0.242** 0.033* 0.429** 0.016 0.025* 0.416** 0.066** 0.004
Triglyceridesa 0.079* 0.117** 0.033* 0.042* 0.122** 0.009 0.047* 0.095* 0.000 0.017
HDL cholesterola 0.043* 0.096* 0.022* 0.056** 0.108** 0.023* 0.068** 0.065* 0.001 0.024*
LDL cholesterol 0.011 0.013 0.002 0.002 0.015 0.005 0.004 0.018 0.009 0.007
SBP Z score 0.188** 0.200** 0.140** 0.014 0.201** 0.007 0.016 0.224** 0.003 0.044*
DBP Z score 0.175** 0.184** 0.130** 0.010 0.176** 0.028* 0.000 0.200** 0.006 0.030*
CRPa 0.146** 0.182** 0.113** 0.043* 0.158** 0.005 0.014 0.233** 0.004 0.102**
Fibrinogena 0.199** 0.208** 0.116** 0.012 0.199** 0.021* 0.001 0.218** 0.006 0.024*
Adiponectina 0.100** 0.143** 0.011 0.047* 0.177** 0.040* 0.085** 0.107** 0.000 0.007
Leptina 0.502** 0.502** 0.412** 0.001 0.502** 0.111** 0.001 0.511** 0.101** 0.019
Resistina 0.095** 0.095* 0.044* 0.000 0.097* 0.017 0.002 0.095* 0.016 0.000
All models were age, sex and pubertal status adjusted
*P-value < 0.05; **P-value < 0.001
aLog-transformed variables
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Table 4 Multivariable DXA prediction of cardiovascular risk factors in youths
Dependent variable Model 1: total fat mass Model 2: total fat mass, trunk/legs fat mass Model 3: total fat mass, trunk fat mass
R2 model 1 R2 model 2 r2 partial total fat mass r2 partial trunk/legs fat mass R2 model 3 r2 partial total fat mass r2 partial trunk fat mass
Fasting glucose 0.058* 0.058* 0.029* 0.000 0.058* 0.004 0.000
Fasting insulina 0.376** 0.425** 0.249** 0.078** 0.395** 0.000 0.030*
HOMA IRa 0.366** 0.412** 0.242** 0.073** 0.383** 0.000 0.027*
QUICKI 0.349** 0.394** 0.213** 0.069** 0.365** 0.000 0.025*
Triglyceridesa 0.046 0.095* 0.029* 0.052* 0.075* 0.016 0.031*
HDL cholesterola 0.015 0.105** 0.014 0.091** 0.066* 0.037* 0.051*
LDL cholesterol 0.010 0.011 0.005 0.001 0.010 0.001 0.000
SBP Z score 0.201** 0.226** 0.183** 0.032* 0.230** 0.004 0.037*
DBP Z score 0.144** 0.178** 0.127** 0.039* 0.181** 0.010 0.042*
CRPa 0.165** 0.198** 0.164** 0.039* 0.186** 0.001 0.025*
Fibrinogena 0.216** 0.216** 0.158** 0.000 0.217** 0.018 0.000
Adiponectina 0.077* 0.137** 0.005 0.065** 0.112** 0.029* 0.038*
Leptina 0.575** 0.578** 0.506** 0.005 0.582** 0.138** 0.015
Resistina 0.100** 0.120** 0.063** 0.022* 0.120** 0.006 0.023*
All models were age, sex and pubertal status adjusted
*P-value < 0.05; **P-value < 0.001
aLog-transformed variables
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findings based on anthropometric measures were in co-
herence with the associations observed between the afore-
mentioned CV risk factors and DXA combinations: total
fat mass and trunk fat mass; respectively total fat mass and
trunk/legs fat mass.
Significant relationships linking unfavourable CV pro-
files to body fat distribution measures, beyond BMI, have
been observed in adults since the pioneer work of Vague.
Vague pointed out abdominal fat toxicity to be responsible
for severe obesities and serious associated prognosis in
adults, in opposition to the gynoid shapes which do not
expose to similar hazardous health complications [44].
Since that study, several epidemiological investigations in
adults showed in particular that, beyond fatness degrees as
assessed by BMI, Waist C and/or WHR, measuring upper
body fat distribution, were significantly correlated with
blood pressure, total serum cholesterol, HDL-cholesterol,
triglycerides level and/or serum insulin level [30–33].
However, the scarce published studies in children about
the usefulness of adding anthropometric surrogates for
body fat distribution to BMI remain controversial. Certain
American paediatric studies reported, exactly as is shown
in the present study, a significant impact of WHR in
addition to BMI, to predict HDL-cholesterol and triglycer-
ides, in youth aged 4–19 years [19, 28]. Gillum [18] also
showed an improvement in blood pressure prediction in
youths (6–17 y) by adding WHR to BMI. Maffeis et al.
[20] showed significant associations between Waist C and
Apo lipoproteins, HDL-cholesterol, total/HDL cholesterol
ratio, blood pressure, after BMI, age and sex adjustments
in prepubertal children aged 3 to 11 years old.
Nevertheless, in 15–16 year-old youths, Lawlor et al.
[15] concluded with the superiority of BMI on Waist C
in predicting blood pressure, fasting glucose and insulin,
triglycerides, LDL and HDL-cholesterol. Only BMI was
also highlighted by Garnett et al. to track CV risk be-
tween childhood and adolescence [13]. Likewise, with a
view to detecting arterial hypertension in 8–10 year-old
children, Maximova et al. recommended the measurement
of BMI rather than Waist C or WHtR [45]. Gillum et al.
[24] showed no significant differences between BMI and
WHR for the prediction of CRP in Mexican American chil-
dren (6–11 y). Similar abilities of BMI-for-age and WHtR
were also shown by Freedman et al. [26] for the screening
of fasting insulin, blood pressure, triacylglycerol, HDL,
LDL and total-to-HDL cholesterol ratio in the Bogalusa
Heart Study.
These controversies may be partly explained by the
different methodologies applied in the studies. Actually,
some studies used continuous data [15, 18–20, 28], while
others analysed categorical data [13, 24, 26, 27, 45].
Indeed, using categorical rather than continuous data
might result in information loss. The lack of standardized
international thresholds to define weight status in children
(e.g., for normal-weight versus overweight and obesity)
may also impact data interpretations. In the current study,
we showed different weight status frequencies according
to two definitions suggested in the literature: 64 % of obes-
ity and 36 % of overweight according to the IOTF defin-
ition [35, 46] and L,M,S Dutch values [42], respectively
80.8 % of obesity and 19.2 % of overweight according to
the WHO definition [47]. The lack of a specific national
percentile distribution of anthropometric data in youths
appears to be an undeniable issue. That constituted a limi-
tation of the current study. However, thanks to the Dutch
L, M, S values provided to us by Dr Van Buuren from
the Department of Statistics, Quality of Life, Leiden,
Netherlands [42, 43], we were able to develop BMI,
Waist C and WHR Z Scores after having checked that
Luxembourgish and Dutch paediatric BMI means were
similar.
The heterogeneity in the relationships between anthro-
pometry and CV risk factors may also be attributed to
the age groups considered in the different studies and/or
to the few biological parameters tested. Our study sample
was characterized by a broad age range and an exhaustive
set of cardiovascular risk factors tested.
The selected nature and relatively small size of our
sample, including only overweight and obese subjects,
might be a limitation of the current study in that it does
not allow the extrapolation of our findings to the general
paediatric population. However, as young people who may
be at higher risk for CV impairments are mostly the over-
weight and obese ones, the current findings might widely
apply to this high-risk population subgroup.
Conclusions
In conclusion, combining BMI Z Score with only one
anthropometric measure for regional fat (i.e., WHR Z
Score, Waist C Z Score and/or WHtR) improves the
prediction of the cardiometabolic, inflammatory and/or
adipokines profiles amongst youth. These findings might
be useful to inform research and clinical activities, and
might help public health authorities to implement a more
appropriate and cost-effective screening of overweight,
obesity and related comorbidities in youth.
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